 | Up a level |
Jump to: 2016
Number of items: 1.
2016
Gerding, D. N., Hecht, D. W., Louie, T., Nord, C. E., Talbot, G. H., Cornely, O. A., Buitrago, M., Best, E., Sambol, S., Osmolski, J. R., Kracker, H., Locher, H. H., Charef, P. and Wilcox, M. (2016). Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C-difficile infection. J. Antimicrob. Chemother., 71 (1). S. 213 - 220. OXFORD: OXFORD UNIV PRESS. ISSN 1460-2091